• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从缓释制剂中回收吗啡:阿片类药物滥用的一个源头。

Recovery of morphine from a controlled-release preparation. A source of opioid abuse.

作者信息

Crews J C, Denson D D

机构信息

Department of Anesthesia, University of Cincinnati College of Medicine, Ohio.

出版信息

Cancer. 1990 Dec 15;66(12):2642-4. doi: 10.1002/1097-0142(19901215)66:12<2642::aid-cncr2820661229>3.0.co;2-b.

DOI:10.1002/1097-0142(19901215)66:12<2642::aid-cncr2820661229>3.0.co;2-b
PMID:2249204
Abstract

MS-Contin (Purdue-Fredrick, Norwalk, CT) is a controlled-release preparation of morphine sulfate that has demonstrated efficacy in the management of chronic cancer pain problems. It has recently come to the attention of the authors that MS-Contin represents a potential source of opioid abuse through the extraction and intravenous injection of the morphine from this preparation. The authors describe a simple aqueous extraction method that was used to quantitatively determine the extent to which morphine could be obtained from MS-Contin tablets.

摘要

美施康定(普渡-弗雷德里克公司,诺沃克,康涅狄格州)是硫酸吗啡控释制剂,已证明对慢性癌痛问题的管理有效。作者最近注意到,美施康定可能通过从该制剂中提取和静脉注射吗啡而成为阿片类药物滥用的一个潜在源头。作者描述了一种简单的水提取方法,该方法用于定量测定从美施康定片剂中获取吗啡的程度。

相似文献

1
Recovery of morphine from a controlled-release preparation. A source of opioid abuse.从缓释制剂中回收吗啡:阿片类药物滥用的一个源头。
Cancer. 1990 Dec 15;66(12):2642-4. doi: 10.1002/1097-0142(19901215)66:12<2642::aid-cncr2820661229>3.0.co;2-b.
2
Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients.口服硫酸吗啡控释片。100毫克片剂对癌症疼痛患者的镇痛效果及副作用。
Cancer. 1989 Jun 1;63(11 Suppl):2284-8. doi: 10.1002/1097-0142(19890601)63:11<2284::aid-cncr2820631137>3.0.co;2-3.
3
The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.
Cancer. 1989 Jun 1;63(11 Suppl):2348-54. doi: 10.1002/1097-0142(19890601)63:11<2348::aid-cncr2820631146>3.0.co;2-v.
4
Abuse-deterrent features of an extended-release morphine drug product developed using a novel injection-molding technology for oral drug delivery.采用新型注射成型技术开发的用于口服给药的缓释吗啡药物产品的抗滥用特性。
J Opioid Manag. 2017 Nov/Dec;13(6):465-472. doi: 10.5055/jom.2017.0406.
5
Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.用于长效镇痛药测试的癌症疼痛模型评估。美施康定在双盲、随机交叉设计中的效果。
Cancer. 1989 Jun 1;63(11 Suppl):2355-9. doi: 10.1002/1097-0142(19890601)63:11<2355::aid-cncr2820631147>3.0.co;2-#.
6
Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.癌症患者对单剂量和多剂量控释吗啡片及吗啡口服溶液的镇痛反应。
Cancer. 1989 Jun 1;63(11 Suppl):2294-7. doi: 10.1002/1097-0142(19890601)63:11<2294::aid-cncr2820631139>3.0.co;2-x.
7
[Respiratory depression following controlled-release morphine sulfate tablets].[硫酸吗啡控释片所致呼吸抑制]
Ned Tijdschr Geneeskd. 1989 Mar 11;133(10):516-7.
8
Evaluation of dosing guidelines for the use of oral controlled-release morphine (MS Contin tablets).口服控释吗啡(美施康定片)用药剂量指南的评估。
Cancer. 1989 Jun 1;63(11 Suppl):2360-4. doi: 10.1002/1097-0142(19890601)63:11<2360::aid-cncr2820631148>3.0.co;2-a.
9
Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.口服吗啡溶液和控释吗啡片在癌症患者中的药代动力学及临床疗效
Cancer. 1989 Jun 1;63(11 Suppl):2275-83. doi: 10.1002/1097-0142(19890601)63:11<2275::aid-cncr2820631136>3.0.co;2-4.
10
Effects of controlled-released morphine on quality of life for cancer pain.控释吗啡对癌痛患者生活质量的影响。
Oncol Nurs Forum. 1989 Jul-Aug;16(4):521-6.

引用本文的文献

1
Aspiration in lethal drug abuse-a consequence of opioid intoxication.药物滥用致死中的吸入-阿片类药物中毒的后果。
Int J Legal Med. 2020 Nov;134(6):2121-2132. doi: 10.1007/s00414-020-02412-y. Epub 2020 Sep 14.
2
Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.通过使用阿片类药物滥用阻止制剂来减轻静脉注射滥用:当前技术概述。
Pain Pract. 2019 Apr;19(4):443-454. doi: 10.1111/papr.12760. Epub 2019 Feb 28.
3
The promotion and marketing of oxycontin: commercial triumph, public health tragedy.
奥施康定的推广与营销:商业上的成功,公共健康的悲剧。
Am J Public Health. 2009 Feb;99(2):221-7. doi: 10.2105/AJPH.2007.131714. Epub 2008 Sep 17.
4
Abuse potential of various opioid medications.各种阿片类药物的滥用可能性。
J Gen Intern Med. 1993 Dec;8(12):688-90. doi: 10.1007/BF02598290.